Bank of New York Mellon Corp - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 31 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,000
-54.5%
18,8790.0%0.00%
Q2 2022$11,000
-8.3%
18,8790.0%0.00%
Q1 2022$12,000
-40.0%
18,8790.0%0.00%
Q4 2021$20,000
-20.0%
18,8790.0%0.00%
Q3 2021$25,000
-34.2%
18,8790.0%0.00%
Q2 2021$38,000
-25.5%
18,8790.0%0.00%
Q1 2021$51,000
-19.0%
18,879
-9.3%
0.00%
Q4 2020$63,00020,8240.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders